Age-dependent increase in ortho-tyrosine and methionine sulfoxide in human skin collagen is not accelerated in diabetes - Evidence against a generalized increase in oxidative stress in diabetes

Journal of Clinical Investigation

Volumn 100, Issue 4, 1997, Pages 839-846

  Wells Knecht, Mary C ^a   Lyons, Timothy J ^c   McCance, David R ^d   Thorpe, Suzanne R ^a   Baynes, John W ^a,b  

^a UNIVERSITY OF SOUTH CAROLINA   (United States)

^b UNIVERSITY OF SOUTH CAROLINA SCHOOL OF MEDICINE   (United States)

^c MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^d ROYAL VICTORIA HOSPITAL   (United Kingdom)

Author keywords

Advanced glycation end products; Carboxymethyllysine; Glycation; Oxidation; Pentosidine

Indexed keywords

3 (2 HYDROXYPHENYL)ALANINE; COLLAGEN; GLYCOSYLATED PROTEIN; METHIONINE SULFOXIDE; N (CARBOXYMETHYL)LYSINE; PENTOSIDINE; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; GLYCATION; HUMAN; HUMAN TISSUE; INSULIN DEPENDENT DIABETES MELLITUS; OXIDATION; OXIDATIVE STRESS; PRIORITY JOURNAL;

EID: 0030866161     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI119599     Document Type: Article

References (48)

1. Baynes, J.W. 1991. The role of oxidative stress in the development of complications in diabetes. Diabetes. 40:405-412.
2. Vlassara, H., R. Bucala, and L. Striker. 1994. Pathogenic effects of advanced glycosylation: biochemical, biologic and clinical implications for diabetes and aging. Lab. Invest. 70:138-151.
3. Sell, D.R., A. Lapolla, P. Odetti, J. Fogarty, and V.M. Monnier. 1992. Pentosidine formation in skin correlates with severity of complications in individuals with long-standing IDDM. Diabetes. 41:1286-1292.
4. McCance, D.R., D.G. Dyer, J.A. Dunn, K.E. Bailie, S.R. Thorpe, J.W. Baynes, and T.J. Lyons. 1993. Maillard reaction products and their relation to the complications of diabetes J. Clin. Invest. 91:2470-2478.
5. Beisswenger, P.J., L.L. Moore, T. Brinck-Johnsen, and T.J. Curphey. 1993. Increased collagen-linked pentosidine levels and advanced glycosylation end products in early diabetic nephropathy. J. Clin. Invest. 92:212-217.
6. Sell, D.R., and V.M. Monnier. 1990. End-stage renal disease and diabetes catalyze the formation of a pentose-derived crosslink from aging human collagen. J. Clin. Invest. 75:380-384.
7. Dyer, D.G., J.A. Dunn, S.R. Thorpe, K.E. Bailie, T.J. Lyons, D.R. McCance, and J.W. Baynes. 1993. Accumulation of Maillard reaction products in skin collagen in diabetes and aging. J. Clin. Invest. 91:2463-2469.
8. Wolff, S.P., and R.T. Dean. 1987. Glucose autoxidation and protein modification: the potential role of autoxidative glycosylation in diabetes. Biochem. J. 245:243-250.
9. Wolff, S.P., Z.Y. Jiang, and J.V. Hunt. 1991. Protein glycation and oxidative stress in diabetes mellitus and ageing. Free Radical Biol. Med. 10:339-352.
10. Baynes, J.W. 1996. The role of oxidation in the Maillard reaction in vivo. In The Maillard Reaction: Consequences for the Chemical and Life Sciences. R. Ikan, editor. John Wiley & Sons Inc., New York. pp. 55-72.
11. Baynes, J.W., and S.R. Thorpe. 1996. The role of oxidative stress in diabetic complications. Curr. Opin. Endocrinol. Diabetes. 3:277-284.
12. Grandhee, S.K., and V.M. Monnier. 1991. Mechanism of formation of the Maillard protein cross-link, pentosidine: glucose, fructose and ascorbate as pentosidine precursors. J. Biol. Chem. 266:11649-11653.
13. Dyer, D.G., J.A. Blackledge, S.R. Thorpe, and J.W. Baynes. 1991. Formation of pentosidine during nonenzymatic browning of proteins by glucose: identification of glucose and other carbohydrates as possible precursors of pentosidine in vivo. J. Biol. Chem. 266:11654-11660.
14. ε-(carboxymethyl)lysine, is a product of both lipid peroxidation and glycoxidation reactions. J. Biol. Chem. 271:9982-9986.
15. Brot, N., and H. Weissbach. 1983. Biochemistry and physiological role of methioninc sulfoxide residues in proteins. Arch. Biochem. Biophys. 223:271-281.
16. Vogt, W. 1995. Oxidation of methionine residues in proteins: tools, targets, and reversal. Free Radical Biol. Med. 18:93-105.
17. Huggins, T.G., M.C. Wells-Knecht, N.A., Detorie, J.W. Baynes, and S.R. Thorpe. 1993. Formation of o-tyrosine and dityrosine in protein during radiolytic and metal-catalyzed oxidation. J. Biol. Chem. 268:12341-12347.
18. Wells-Knecht, M.C., T.G. Huggins, D.G. Dyer, S.R. Thorpe, and J.W. Baynes. 1993. Oxidized amino acids in lens proteins with age. Measurement of o-tyrosine and dityrosine in the aging human lens. J. Biol. Chem. 268:12348-12352.
19. Knecht, K.J., J.A. Dunn, K.F. McFarland, S.R. Thorpe, and J.W. Baynes. 1991. Oxidative degradation of glycated proteins: effect of diabetes and aging on carboxymethyllysine levels in human urine. Diabetes. 40:190-196.
20. Fu, M.-X., K.J. Knecht, S.R. Thorpe, and J.W. Baynes. 1992. Role of oxygen in the crosslinking and chemical modification of protein by glucose. Diabeles. 41(Suppl. 2):42-48.
21. Fu, M.-X., K.J. Wells-Knecht, J.A. Blackledge, T.J. Lyons, S.R. Thorpe, and J.W. Baynes. 1994. Glycation, glycoxidation and crosslinking of collagen by glucose: kinetics, mechanisms and inhibition of late stages of the Maillard reaction. Diabetes. 43:676-683.
22. Wells-Knecht, M.C., S.R. Thorpe, and J.W. Baynes. 1995. Pathways of formation of glycoxidation products during glycation of collagen. Biochemistry. 34:15134-15141.
23. Watkins, N.G., C.I. Neglia, D.G. Dyer, S.R. Thorpe, and J.W. Baynes. 1987. Effects of phosphate on the kinetics and specificity of glycation of protein. J. Biol. Chem. 262:7207-7212.
24. Zyzak, D.V., J.M. Richardson, S.R. Thorpe, and J.W. Baynes. 1995. Formation of reactive intermediates from Amadori compounds under physiological conditions. Arch. Biochem. Biophys. 316:547-554.
25. Finot, P.A., and D.E. Furniss. 1986. Nephrocytomegaly in rats induced by Maillard reaction products: the involvement of metal ions. Dev. Food Sci. 13: 493-502.
26. Jiang, Z.Y., A.C.S. Woolard, and S.P. Wolff. 1990. Hydrogen peroxide generation during experimental protein glycation. FEBS Lett. 268:69-71.
27. Elgawish, A., M. Glomb, M. Friedlander, and V.M. Monnier. 1996. Involvement of hydrogen peroxide in collagen cross-linking by high glucose in vitro and in vivo. J. Biol. Chem. 271:12964-12971.
28. Williamson, J.R., K. Chang, M.F. Khalid, K.S. Hasan, Y. Ido, T. Kawamura, J.R. Nyengaard, M. Van den Enden, C. Kilo, and R.G. Tilton. 1993. Hyperglycemic pseudohypoxia and diabetic complications. Diabetes. 42:801-813.
29. Cameron, N.E., and M.A. Cotter. 1993. Potential therapeutic approaches to the treatment or prevention of diabetic neuropathy: evidence from experimental studies. Diabetic Medicine. 10:593-605.
30. Baynes J.W. 1995. Reactive oxygen in the aetiology and complications of diabetes. In Drugs, Diet and Disease. Vol. 2: Mechanistic Approaches to Diabetes. C. Ioannides, editor. Pergamon Press, London. 203-240.
31. Giugliano, D., A. Ceriello, and G. Paolisso. 1996. Oxidative stress and diabetic vascular complications. Diabetes Care. 19:257-265.
32. Lyons, T.J., and A.J. Jenkins. 1996. Glycation, oxidation, and lipoxidation in the development of the complications of diabetes mellitus: a carbonyl stress hypothesis. Diab. Rev. In press.
33. Van Dam, P.S., B.S. Van Asbeck, D.W. Erkelens, J.J. M. Marx, W.H. Gispen, and B. Bravenboer. 1996. The role of oxidative stress in neuropathy and other diabetic complications. Diabetes Metab. Rev. 11:181-192.
34. Kunisaki, M., S.E. Bursell, A.C. Clermont, H. Ishii, L.M. Ballas, M.R. Jirousek, F. Umeda, H. Nawata, and G.L. King. 1995. Vitamin E prevents diabetes-induced abnormal retinal blood flow via the diacylglycerol-protein kinase C pathway. Am. J. Physiol. 269:E239-E246.
35. Cameron, M.A., A, Love, M.J. Watt, N.F. Cameron, and K.C. Dines. 1995. Effects of natural free radical scavengers on peripheral nerve and neurovascular function in diabetic rats. Diabetologia. 38:1285-1294.
36. Sagara, M., J. Satoh, R. Wada, S. Yagihashi, K. Takahashi, M. Fukuzawa, G. Muto, Y. Muto, and T. Toyota. 1996. Inhibition of development of peripheral neuropathy in streptozotocin-induced diabetic rats with N-acetylcysteine. Diabetologia. 39:263-269.
37. Keegan, A., H. Walbank, M.A. Cotter, and N.E. Cameron. 1995. Chronic vitamin E treatment prevents defective endothelium-dependent relaxation in diabetic rat aorta. Diabetologia. 38:1475-1478.
38. Requena, J.R., and J.W. Baynes. 1997. Studies in animal models on the role of glycation and advanced glycation end-products (AGEs) in the pathogenesis of diabetic complications: pitfalls and limitations. In Lessons from Animal Diabetes. Vol. VII. A. Sima, editor. Birkhäuser, Boston. In press.
39. Makita, Z., S. Radoff, E.J. Rayfield, Z. Yang, E. Skolnik, V. Delaney, E.A. Friedman, A. Cerami and H. Vlassara. 1991. Advanced glycosylation end products in patients with diabetic nephropathy. N. Engl. J. Med. 325:836-842.
40. Papastanasiou, P., L. Grass, H. Rodela, A. Patrikarea, D. Oreopoulos, and E.P. Diamandis. 1994. Immunological quantification of advanced glycosylation end-products in the serum of patients on hemodialysis or CAPD. Kidney Int. 46:216-222.
41. Ceriello, A., P. dello Russo, P. Armstad, and P. Cerutti. 1996. High glucose induces antioxidant enzymes in human endothelial cells in culture: evidence linking hyperglycemia and oxidative stress. Diabetes. 45:471-477.
42. Schmidt, A.M., O. Hori, J. Brett, S.-D. Yan, J.L. Wautier, and D. Stern. 1994. Cellular receptors for advanced glycation end products: implications for induction of oxidant stress and cellular dysfunction in the pathogenesis of vascular lesions. Arterioscler. Thromb. 14:1521-1528.
43. Godin, D.V., and S.A. Wohaieb. 1988. Reactive oxygen processes in diabetes. In Oxygen Radicals in Pathophysiology of Heart Disease. P.K. Singal, editor. Kluwer Academic Publishers, Norwell, MA. pp. 302-322.
44. Oberley, L.W. 1988. Free radicals and diabetes. Free Radical Biol. Med. 5:113-124.
45. Stadtman, E.R. 1995. Role of oxidized amino acids in protein breakdown and stability. Methods Enzymol. 258:379-393.
46. Requena, J.R., M.-X. Fu, M.U. Ahmed, A.J. Jenkins, T.J. Lyons, J.W. Baynes, and S.R. Thorpe. 1997. Quantitation of malondialdehyde and 4-hydroxy-nonenal adducts to lysine residues in native and oxidized human low-density lipoprotein. Biochem J. 322:317-325.
47. Harman, D. 1992. Role of free radicals in aging and disease. Ann. NY Acad. Sci. 673:126-141.
48. Weindruch, R., and R.L. Walford. 1988. The Retardation of Aging and Disease by Dietary Restriction. Charles C. Thomas, Publisher, Springfield, IL. 436 pp.